Trials / Conditions / Recurrent Ovarian Low Grade Serous Adenocarcinoma
Recurrent Ovarian Low Grade Serous Adenocarcinoma
3 registered clinical trials studyying Recurrent Ovarian Low Grade Serous Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents NCT04739800 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With NCT04092270 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Ca NCT02101788 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |